Bitcoin faced a double blow on Tuesday from heightened geopolitical risks and the disclosure of a bitcoin sale by corporate treasury giant Strategy, briefly dipping to the $70,000 mark. As of press time, BTC traded at $70,749, down 3.6% in 24 hours. Ethereum fell 0.1% to $1,995, while BNB lost 1.8%, XRP dropped 3%, and Solana slid 1.8%.
Middle East Flashpoint Sends High-Beta Assets Reeling
Dominick John of Zeus Research attributed the sell-off to surging risk aversion after Iran broke off talks with the U.S. in protest of Israeli military action in Lebanon. President Trump later said negotiations were still “moving very rapidly,” but CNN reported a heated dispute between Trump and Israeli PM Netanyahu over military plans. Investors dumped high-beta assets including crypto amid fears of instability in the Strait of Hormuz.
Strategy Breaks 'Never Sell' Vow, Shakes Retail Confidence
On top of macro jitters, the news that Strategy sold 32 BTC at an average of $77,135 between May 26-31 to raise $2.5 million for preferred dividend payments rattled the market. BTSE COO Jeff Mei said the amount is trivial, but the signal is dangerous — even one of the largest bitcoin corporate holders is feeling financial pressure from the recent price slide. CoinEx Chief Analyst Jeff Ko warned the sale “breaks the firm’s long-held narrative of steadfast holding, psychologically devastating retail investors and darkening an already fragile landscape.”
Presto Research Head Peter Chung cautioned that unless Strategy’s next move injects fresh confidence, skeptics will wonder whether this tiny sale was a precautionary move or “the prelude to a more aggressive sell-off.”
U.S. stocks hit new highs Monday (S&P 500 +0.3%, Nasdaq +0.4%), but Asian markets were mixed Tuesday: Japan’s Nikkei 225 fell 1.64%, South Korea’s Kospi slid 2.14%, while Hong Kong’s Hang Seng rose 1.01% and China’s CSI 300 gained 0.75%.
Traders are now watching Middle East developments and whether bitcoin can defend the $70,000 psychological support level, according to Zeus Research’s John.